Hormone-dependent spinal leiomyoma.
A 43-year-old woman underwent subtotal removal of a cervical spinal leiomyoma in 1980 and 1981. When her (cyclic) symptoms recurred and tumor growth was demonstrated, she was treated with a synthetic anti-gonadotropic hormone (Danazol; Danatrol) until menopause, when medication could be discontinued without further recurrence of her symptoms or increase in size of the residual tumor.
Hekster
R E
RE
Department of Radiology, Leyenburg Hospital, Den Haag, The Netherlands.
Lambooy
N
N
van Hall
E V
EV
Kazzaz
B A
BA
van Rijssel
E J
EJ
D000328:Adult; D002574:Cervical Vertebrae; D003613:Danazol / Q000627:therapeutic use; D004967:Estrogens / Q000502:physiology*; D005260:Female; D006801:Humans; D007889:Leiomyoma / Q000188:drug therapy / Q000503:physiopathology*; D013125:Spinal Neoplasms / Q000188:drug therapy / Q000503:physiopathology*
D004967:Estrogens; D003613:Danazol